Joy Behar Reveals GLP-1 Weight Loss: 'I Was Prediabetic' on The View

In a candid moment on ABC's The View, co-host Joy Behar revealed her personal experience with GLP-1 medications for weight loss, disclosing that she was prediabetic. This revelation ties into Hollywood's hottest trend: celebrities turning to drugs like Ozempic, Mounjaro, and other GLP-1 agonists for transformative health improvements. Behar's story, alongside those of her co-hosts, underscores the growing popularity of these therapies among high-profile figures seeking metabolic health benefits.

Joy Behar's Candid GLP-1 Revelation

Joy Behar didn't hold back during a lively discussion on the show. She joked, "We lost a ton of weight at this table," highlighting the collective weight loss experiences among the The View panel. Behar specifically shared that she was prediabetic, a condition affecting blood sugar regulation that often precedes type 2 diabetes. By using GLP-1 medications, she has achieved noticeable weight loss, aligning with the drugs' reputation for aiding those with prediabetes and obesity-related risks.

Prediabetes affects millions, characterized by elevated blood sugar levels that increase heart disease and diabetes risks. Behar's openness brings attention to how GLP-1 therapies, originally developed for diabetes management, are now widely used off-label for weight loss in prediabetic individuals.

Sunny Hostin's Mounjaro Success Story

Co-host Sunny Hostin provided even more specifics about her journey. "During COVID, I gained 40 lbs. All I did was eat... I love to cook, and I found out, I love to eat. And I was horrified about the fact that I would have to come out on air," she explained on a 2024 episode. To address this, Hostin turned to Mounjaro.

The results were striking: "I found that my cholesterol went up to 200 when I gained the extra weight. And I use Mounjaro and my cholesterol is 140 now," the former attorney continued. "I feel better, I think I look better, and that's what this is about for people." Hostin's experience illustrates Mounjaro's dual benefits in weight reduction and lipid profile improvement, common outcomes in clinical use.

Hollywood's Embrace of Ozempic, Mounjaro, and GLP-1 Drugs

The conversation on The View reflects a broader celebrity trend. Stars have publicly credited Ozempic (semaglutide) and Mounjaro (tirzepatide) for dramatic weight loss. These GLP-1 receptor agonists mimic hormones that regulate appetite and insulin, making them effective for sustained weight management. While some women on the panel, including Sunny Hostin, specifically used Mounjaro, the buzz around these drugs has made them synonymous with Hollywood's push for health and vitality.

What Are GLP-1 Medications and How Do They Work?

Mechanism of Action

GLP-1 (glucagon-like peptide-1) medications like Ozempic and Mounjaro work by activating GLP-1 receptors in the body. This leads to slowed gastric emptying, reduced appetite, and increased insulin secretion in response to meals. For prediabetic individuals like Joy Behar, they help stabilize blood sugar. Tirzepatide in Mounjaro also targets GIP receptors, enhancing its weight loss efficacy compared to semaglutide alone.

These effects explain Sunny Hostin's cholesterol drop from 200 to 140, as weight loss often correlates with improved lipid levels and reduced cardiovascular risk.

Ozempic vs. Mounjaro: Key Comparisons

• Ozempic (semaglutide): Weekly injection, FDA-approved for type 2 diabetes and chronic weight management. Popular for steady, sustainable results.
• Mounjaro (tirzepatide): Dual-action GLP-1/GIP agonist, showing superior weight loss in trials (up to 20-25% body weight reduction). Hostin's 40-lb loss aligns with such outcomes.

Both are self-administered via pen injector, with dosing starting low to minimize side effects.

Benefits for Prediabetes, Weight Loss, and Beyond

Stories like Behar's and Hostin's highlight GLP-1 drugs' role in addressing prediabetes—a state where fasting blood sugar is 100-125 mg/dL. By promoting weight loss, they lower diabetes progression risk by up to 50% in studies. Improved cholesterol, as seen with Hostin, reduces heart disease odds, a key concern for overweight individuals.

Additional perks include better energy, mood, and appearance, echoing Hostin's sentiment: "I feel better, I think I look better."

Safety Profile and Common Side Effects

GLP-1 medications are generally well-tolerated but can cause nausea, vomiting, diarrhea, and constipation, especially during initiation. Rare risks include pancreatitis or gallbladder issues. Patients like those on The View should monitor with regular check-ups. Tools like Shotlee can help track symptoms, side effects, or medication schedules for better adherence.

Contraindications include personal/family history of medullary thyroid carcinoma. Always consult a healthcare provider before starting.

Who Should Consider GLP-1 Therapy? Patient Guidance

Ideal candidates mirror Behar and Hostin: those with prediabetes, obesity (BMI ≥30), or weight-related comorbidities like high cholesterol. Discuss with your doctor if you:

• Struggled with weight gain, like Hostin's 40 lbs during COVID.
• Have prediabetes or elevated lipids.
• Seek non-surgical weight loss options.

Lifestyle integration—diet, exercise—amplifies results. Compare to alternatives like phentermine (short-term) or bariatric surgery (invasive). GLP-1s offer a middle ground with proven long-term data.

Key Takeaways: What This Means for Patients

• Joy Behar's GLP-1 use addressed her prediabetes, contributing to panel-wide weight loss.
• Sunny Hostin lost significant weight with Mounjaro, dropping cholesterol from 200 to 140.
• These celebrity stories spotlight GLP-1s' real-world impact on metabolic health.
• Consult professionals; track progress for optimal outcomes.

Conclusion: Actionable Insights from The View

Joy Behar's revelation and Sunny Hostin's detailed Mounjaro success affirm GLP-1 medications' value for prediabetes, weight loss, and cholesterol management. Hollywood's trend validates their efficacy, but personalized medical advice is essential. If you're prediabetic or facing similar challenges, talk to your doctor about Ozempic, Mounjaro, or GLP-1 options to potentially transform your health like these stars.